U.S. markets open in 9 hours 4 minutes

Becton, Dickinson and Company (BDXB)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
53.44-0.20 (-0.37%)
At close: 4:00PM EDT

Becton, Dickinson and Company

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
201 847 6800
http://www.bd.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees70,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Thomas E. Polen Jr.Pres, CEO & Chairman2.11M1.72M1973
Mr. Christopher R. ReidyExec. VP, CFO & Chief Admin. Officer1.4MN/A1957
Mr. Samrat S. KhichiExec. VP of Regulatory & Gov. Affairs and Gen. Counsel2.19MN/A1967
Mr. Alberto MasExec. VP & Pres of the Medical Segment1.15M1.64M1961
Mr. Thomas J. SpoerelVP, Controller & Chief Accounting OfficerN/AN/A1978
Ms. Elizabeth McCombsExec. VP & Chief Technology OfficerN/AN/A1976
Jerry FlaszExec. VP of Global Services & Chief Information OfficerN/AN/AN/A
Ms. Monique N. DoleckiSr. VP of Investor RelationsN/AN/AN/A
Michelle QuinnSr. VP and Chief Ethics & Compliance OfficerN/AN/AN/A
Troy KirkpatrickVP of PRN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Corporate Governance

Becton, Dickinson and Company’s ISS Governance QualityScore as of June 1, 2021 is 9. The pillar scores are Audit: 6; Board: 7; Shareholder Rights: 10; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.